Comparison of point-of-care methods for preparation of platelet concentrate (platelet-rich plasma)

International Journal of Oral and Maxillofacial Implants

Volumn 27, Issue 4, 2012, Pages 762-769

  Weibrich, Gernot ^a   Kleis, Wilfried K G ^a   Streckbein, Philipp ^a,b   Moergel, Maximilian ^a   Hitzler, Walter E ^a   Hafner, Gerd ^a  

^a JOHANNES GUTENBERG UNIVERSITY   (Germany)

^b JUSTUS LIEBIG UNIVERSITY   (Germany)

Author keywords

Growth factors; Leukocyte; Platelet concentrate; Platelet rich plasma; Production process

Indexed keywords

PLATELET DERIVED GROWTH FACTOR; PLATELET-DERIVED GROWTH FACTOR AB; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

BLOOD BANK; CHEMISTRY; COMPARATIVE STUDY; CYTOLOGY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; HOSPITAL INFORMATION SYSTEM; HUMAN; LEUKOCYTE; LEUKOCYTE COUNT; MALE; PROCEDURES; SEX DIFFERENCE; THROMBOCYTE; THROMBOCYTE COUNT; THROMBOCYTE RICH PLASMA; THROMBOCYTOPHERESIS;

BLOOD BANKS; BLOOD PLATELETS; ENZYME-LINKED IMMUNOSORBENT ASSAY; FEMALE; HUMANS; LEUKOCYTE COUNT; LEUKOCYTES; MALE; PLATELET COUNT; PLATELET-DERIVED GROWTH FACTOR; PLATELET-RICH PLASMA; PLATELETPHERESIS; POINT-OF-CARE SYSTEMS; SEX FACTORS; TRANSFORMING GROWTH FACTOR BETA; TRANSFORMING GROWTH FACTOR BETA1;

EID: 84870736025     PISSN: 08822786     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (27)

1. Banks RE, Forbes MA, Kinsey SE, et al. Release of the angiogenic cytokine vascular endothelial growth factor (VEGF) from platelets:Significance for VEGF measurements and cancer biology. Br J Cancer 1998;77:956-964.
2. Kassolis JD, Rosen PS, Reynolds MA. Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freezedried bone allograft: Case series. J Periodontol 2000;71:1654-1661.
3. Kiuru J, Viinikka L, Myllyla G, Pesonen K, Perheentupa J. Cytoskeleton- dependent release of human platelet epidermal growth factor. Life Sci 1991;49:1997-2003.
4. Marx RE, Carlson ER, Eichstaedt RM, Schimmele SR, Strauss JE, Georgeff KR. Platelet-rich plasma: Growth factor enhancement for bone grafts. Oral Surg Oral Med Oral Pathol Oral Radiol Endod 1998;85:638-646.
5. Marx RE (ed). Platelet-Rich Plasma: A Source of Multiple Autologous Growth Factors for Bone Grafts. Chicago: Quintessence, 1999.
6. Kim SG, Kim WK, Park JC, Kim HJ. A comparative study of osseointegration of Avana implants in a demineralized freeze-dried bone alone or with platelet-rich plasma. J Oral Maxillofac Surg 2002;60:1018-1025.
7. Kim SG, Chung CH, Kim YK, Park JC, Lim SC. Use of particulate dentin-plaster of Paris combination with/without platelet-rich plasma in the treatment of bone defects around implants. Int J Oral Maxillofac Implants 2002;17:86-94.
8. Zechner W, Tangl S, Tepper G, et al. Influence of platelet-rich plasma on osseous healing of dental implants: A histologic and histomorphometric study in minipigs. Int J Oral Maxillofac Implants 2003;18:15-22.
9. Weibrich G, Kleis WKG, Hafner G, Hitzler WE, Wagner W. Comparison of platelet, leukocyte, and growth factor levels in point-of-care platelet-enriched plasma, prepared using a modified Curasan kit, with preparations received from a local blood bank. Clin Oral Implants Res 2003;14:357-362.
10. Weibrich G, Kleis WKG, Buch RSR, Hitzler WE, Hafner G. The Harvest SmartPReP system versus the Friadent-Schütze platelet-rich plasma kit: Comparison of a half-automatic with a more complex method for the preparation of platelet-concentrates. Clin Oral Implants Res 2003;14:233-239.
11. Weibrich G, Buch RSR, Kleis WKG, Hafner G, Hitzler WE, Wagner W. Quantification of thrombocyte growth factors in platelet concentrates produced by discontinuous cell separation. Growth Factors 2002;20:93-97.
12. Weibrich G, Kleis WKG, Hafner G. Growth factor levels in the platelet-rich plasma produced by two different methods: Curasantype PRP kit versus PCCS PRP System. J Oral Maxillofac Implants 2002;17:184-190.
13. Weibrich G, Kleis WGK, Hafner G, Hitzler WE. Growth factor levels in platelet-rich plasma and correlations with donor age, sex, and platelet count. J Craniomaxillofac Surg 2002;30:97-102.
14. Wadhwa M, Seghatchian MJ, Lubenko A, et al. Cytokine levels in platelet concentrates: Quantitation by bioassays and immunoassays. Br J Haematol 1996;93:225-234.
15. Wagner W, Foitzik C. Praxistaugliches Verfahren zur Gewinnung von Platelet-rich Plasma [in German]. Z Zahnärztl Implantol 2000;16:146-150.
16. Appel TR, Potzsch B, Muller J, Von Lindern JJ, Berge SJ, Reich RH. Comparison of three different preparations of platelet concentrates for growth factor enrichment. Clin Oral Implants Res 2002;13:522-528.
17. Anitua E. Plasma rich in growth factors: Preliminary results of use in the preparation of future sites for implants. Int J Oral Maxillofac Implants 1999;14:529-535.
18. Anitua E. The use of plasma-rich growth factors (PRGF) in oral surgery. Pract Proced Aesthet Dent 2001;13:487-493.
19. Sekido Y, Morishima Y, Ohya K. Activity of platelet-derived growth factor (PDGF) in platelet concentrates and cryopreserved platelets determined by PDGF bioassay. Vox Sang 1987;52:27-30.
20. Jiang X, Kanai H, Hiromura K, Sawamura M, Yano S. Increased intraplatelet and urinary transforming growth factor-beta in patients with multiple myeloma. Acta Haematologica 1995;94:1-6.
21. Ito J, Kamiya Y, Kawaguchi M. Increased content of epidermal growth factor in platelet lysates in non-insulin-dependent diabetes mellitus. Life Sci 1993;53:717-724.
22. Pencev D, Grotendorst G. Human peripheral blood monocytes secrete a unique form of PDGF. Oncogene Res 1988;3:333-342.
23. Grotendorst G, Smale G, Pencev D. Production of transforming growth factor beta by human peripheral blood monocytes and neutrophils. J Cell Physiol 1989;140:396-402.
24. Bühling F, Thölert G, Kaiser D, et al. Increased release of transforming growth factor (TGF)-β1, TGF-β2, and chemoattractant mediators in pneumonia. J Interferon Cytokine Res 1999;19:271-278.
25. Sonnleitner D, Huemer P, Sullivan DY. A simplified technique for producing platelet-rich plasma and platelet concentrate for intraoral bone grafting techniques: A technical note. Int J Oral Maxillofac Implants 2000;15:879-882.
26. Whitman DH, Berry RL, Green DM. Platelet gel: An autologous alternative to fibrin glue with applications in oral and maxillofacial surgery. J Oral Maxillofac Surg 1997;55:1294-1299.
27. Tetsch J, Homann J, Tetsch P. Untersuchungen zum postoperativen Beschwerdeprofil nach Einsatz von plättchenreichem Plasma (PRP) [in German]. Z Zahnärztl Implantol 2004;20:87-93.